Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells

doi:10.3748/wjg.14.1491

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5354)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

613

HTML

4272

Figures (1-4)

268

Tables (1-3)

201

Sum=5354

Mar 14, 2008 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (64)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Mar 14, 2008; 14(10): 1491-1497
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1491

Full Size Figure Download Figure

Figure 2 Cytotoxic effects of different concentrations of doxorubicin (A) and cisplatin (B) on cancer cell lines. The percentage of cell growth was measured using SRB staining assay. Each value represents the mean ± SE of three independent experiments.

Citation: Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol 2008; 14(10): 1491-1497
URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1491.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1491